Price Target Changes｜Microsoft Reduced to $330 By Keybanc; Eli Lilly Raised to $355 By Barclays
Benzinga2022-07-07
- Truist Securities cut Criteo S.A. price target from $40 to $35. Criteo shares fell 3.5% to close at $22.92 on Wednesday.
- Barclays raised Eli Lilly price target from $333 to $355. Eli Lilly shares fell 0.3% to $329.29 in pre-market trading.
- Credit Suisse cut the price target on MarketAxess Holdings Inc. from $316 to $305. MarketAxess shares fell 1.9% to close at $259.63 on Wednesday.
- UBS cut the price target on Kellogg Company from $81 to $74. Kellogg shares dropped 1.3% to $71.80 in pre-market trading.
- Daiwa Capital raised Merck & Co., Inc. price target from $89 to $102. Merck shares fell 1.4% to $91.81 in pre-market trading.
- RBC Capital cut The Boston Beer Company, Inc. price target from $488 to $331. Boston Beer shares fell 0.5% to $304.85 in pre-market trading.
- Mizuho cut CytomX Therapeutics, Inc. price target from $16 to $4. CytomX Therapeutics shares fell 28.9% to $1.40 in pre-market trading.
- Keybanc reduced the price target for Microsoft Corporation from $373 to $330. Microsoft shares rose 0.2% to $266.85 in pre-market trading.
- Citigroup lowered price target for DoorDash, Inc. from $138 to $118. DoorDash shares rose 0.4% to $69.66 in pre-market trading.
- Keybanc reduced the price target on Intuit Inc. from $500 to $450.. Intuit shares rose 1% to $408.76 in pre-market trading.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
